BioSpace News Archive

Policy

Otsuka-Partnered Mindset Wins Patent Allowance for Psychedelic CNS Assets

Mindset Pharma was granted allowance by the U.S. Patent and Trademark Office for its application for a psilocybin-based family of drugs to treat central nervous system disorders.

July 6, 2022
·
3 min read
·
Mark Terry
Business

Boehringer, Evotec and bioMérieux Recognize AMR Threat and More Deals

Boehringer, Evotec and bioMérieux found Aurobac to combat antimicrobial resistance, Turnstone and Moffitt Expand TIL Collab, Skyhawk to gain potential $2B from Sanofi RNA splicing deal.

July 6, 2022
·
4 min read
·
Alex Keown
Policy

Analyst: Value of Accelerated Approvals Exceeds Minimal Medicaid Costs

Emory University’s Ken Thorpe told BioSpace that the average Medicaid spending on drugs approved under the accelerated pathway in relation to total Medicaid spending is.2%.

July 6, 2022
·
4 min read
·
Alex Keown
Drug Development

Inmagene and HUTCHMED Announce First Participants in Global Phase I Trial of IMG-007

Inmagene Biopharmaceuticals and HUTCHMED Limited announces that the first participant, based in Australia, was dosed in a global Phase I trial of IMG-007, an investigational OX40 antagonistic monoclonal antibody.

July 6, 2022
·
6 min read
Glaucoma Treatment Market: North America to Remain Leading Revenue Contributor to Global Market

Wilmington, Delaware, United States, Transparency Market Research Inc.: Glaucoma is considered to be the second most cause for blindness around the world, according to WHO.

July 6, 2022
·
10 min read
Human Papillomavirus Vaccine Market: Increasing Prevalence of Various Cancers caused by Human Papillomavirus to Drive the Market

Wilmington, Delaware, United States, Transparency Market Research Inc.: Human papillomaviruses cause various types of cancers such as cervical cancer, anal cancer, vaginal cancer, penile cancer, vulvar cancer, oropharyngeal cancer, and genital warts.

July 6, 2022
·
8 min read
Healthcare Software As A Service Market: Growing Application of Software Trends in the Healthcare Sector, 2031

The healthcare software as a service market is likely to create multiple opportunities during the forecast period of 2021-2031, owing to the penetration of innovative technologies in the healthcare industry.

July 6, 2022
·
7 min read
Self-Health Kits Market: Competitive Landscape | Growth Drivers | Geographical Insights, 2031

The rise in geriatric population and their vulnerability to various diseases increases hospital visits for proper check-up.

July 6, 2022
·
7 min read
Wearable Brain Devices Market: Future Market Demand and New Growth Opportunities, Analysis 2031

The rising prevalence of neurological disorders across the world is a prime factor boosting the growth of the global wearable brain devices market.

July 6, 2022
·
7 min read
South Asia and East Asia Self-Administered Medication Market Is Projected To Expand At A CAGR Of 8.9% And 8.7% Respectively In Coming Years.

Fact.MR, a market research and competitive intelligence provider: The global self-administered medication market is estimated at USD 87.5 Billion in 2022 and is forecast to surpass USD 200.5 Billion by 2032, growing at a CAGR of 8.6% from 2022 to 2032.

July 6, 2022
·
9 min read